Clinical Trial Update: Phimume® Percutaneous Left Ventricular Assist System Study [NA]

View source ↗

Summary

Update on the Phimume Percutaneous Left Ventricular Assist System trial for coronary artery disease indicates the study is not yet recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Snippet

Sponsor: Shanghai NewMed Medical Co., Ltd. | Conditions: Coronary Artery Disease | NA | Status: NOT_YET_RECRUITING